Loading...
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
Background: Immunotherapy has drastically changed the outlook for melanoma patients over the past decade. Specifically, the dual blockade of immune checkpoints using ipilimumab and nivolumab has shown unprecedented response rates and survival outcomes. This immense achievement, though, is at the cos...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7464656/ https://ncbi.nlm.nih.gov/pubmed/32824780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082329 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|